iPSC-Derived NK Cells Pipeline The iPSC-derived NK cells therapeutic landscape is entering a transformative phase, driven by cutting-edge advancements in cellular engineering, scalable manufacturing, and next-generation immuno-oncology approaches. iPSC-Derived NK Cells Pipeline Set to Transform Cancer Immunotherapy Landscape with 15+ … Continue reading
